Evidence review
Berberine and blood sugar: human evidence reviewed
Meta-analyses of randomised trials in adults with type 2 diabetes report that berberine lowers HbA1c by roughly 0.6 to 0.7 percentage points on average, with reductions in fasting glucose. The evidence is more consistent than for most supplements, but it comes largely from small trials of variable quality, often combined with existing treatment, and berberine has meaningful drug interactions and should not be used in pregnancy.
Ingredient evidence ≠ product proof
This page reviews research on an ingredient. It does not show that any branded supplement containing that ingredient works, because commercial products may use a different form, dose or combination, and are rarely tested themselves. This is an evidence page: it contains no affiliate links.
The research question
Does berberine lower blood glucose and HbA1c in people with raised blood sugar, and how reliable is that evidence?
Evidence table: population → dose → duration → result → limitations
| Study | Population | Dose / intervention | Duration | Result | Limitations |
|---|---|---|---|---|---|
| 2022 meta-analysis | 37 RCTs; 3,048 people with type 2 diabetes | Berberine vs control; doses varied | Mostly weeks to months | HbA1c about −0.63 points; fasting glucose about −0.82 mmol/L | Pooled small trials; varied doses and background treatment |
| 2021 meta-analysis | RCTs in type 2 diabetes | Berberine alone or with standard therapy | Varied | HbA1c about −0.73 points | Overlapping trial pool |
| 2024 meta-analysis | 50 studies; 4,150 participants | Berberine alone or combined with glucose-lowering drugs | Varied | Combination improved HbA1c (about −0.69 points) | Cannot isolate berberine’s independent effect in combination arms |
| 2012 meta-analysis (PMC3478874) | 14 RCTs; 1,068 participants | Berberine vs lifestyle, placebo or oral drugs | Varied | Lowered glucose vs lifestyle or placebo; not significantly better than metformin, glipizide or rosiglitazone | Methodological quality generally low |
| NCT02365480 protocol (background) | Summary of prior clinical use | Oral doses up to 1,500 mg/day | Up to 3 months | Mild–moderate constipation reported in 3–8% of participants in earlier studies | Background summary, not a new trial result |
What the results show
Across several independent meta-analyses the direction of effect is consistent: berberine lowers HbA1c and fasting glucose compared with control in type 2 diabetes. The size — around 0.6 to 0.7 percentage points of HbA1c — is clinically relevant if real, but the same body of mostly small trials feeds each analysis, so agreement between reviews is not the same as independent confirmation. The older 2012 review found berberine was not significantly better than common oral diabetes drugs and rated trial quality as generally low. NCCIH summarises the diabetes supplement evidence overall as weak evidence of possible benefit.
What the research does not prove
- That berberine prevents diabetes or its complications.
- That it replaces metformin or other prescribed treatment.
- That effects seen in type 2 diabetes apply to people with normal blood sugar.
- That a branded blend containing berberine at an undisclosed dose produces the same result.
Safety
- Digestive effects (constipation, diarrhoea, cramping) are the most commonly reported.
- Berberine should not be used in pregnancy, breastfeeding or in infants; it has been linked to harmful bilirubin build-up in infants (NCCIH berberine fact page).
- It inhibits drug-metabolising liver enzymes and can add to diabetes medicines, raising the risk of low blood sugar (Endotext).
Limitations of the evidence base
- Many trials were conducted in a single country, limiting generalisability.
- Trials were short relative to diabetes management.
- Different formulations and doses were pooled.
- Few data on hard outcomes such as cardiovascular events.
Frequently asked questions
How much does berberine lower HbA1c?
Meta-analyses report average reductions of roughly 0.6–0.7 percentage points in type 2 diabetes, from mostly small trials.
Is berberine as good as metformin?
An older meta-analysis found it was not significantly better than common oral drugs; there are no large high-quality head-to-head trials establishing equivalence.
Who should avoid berberine?
Pregnant or breastfeeding people, infants, and people taking medicines that could interact, unless a clinician advises otherwise.
Related on FactoWiki
Berberine ingredient guide · Berberine dosage for blood sugar · Blood sugar category
References
- Glucose-lowering effect of berberine on type 2 diabetes: systematic review and meta-analysis. 2022. PMID 36467075
- The effect of berberine on metabolic profiles in type 2 diabetic patients: systematic review and meta-analysis of RCTs. 2021. PMID 34956436
- Effects of administering berberine alone or in combination on type 2 diabetes mellitus: systematic review and meta-analysis. 2024. PMID 39640489
- Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. 2012. PMC3478874
- NCCIH: Diabetes and dietary supplements.
- NCCIH berberine fact page.
- Endotext: complementary and integrative approaches for type 2 diabetes. NBK279062
- ClinicalTrials.gov NCT02365480 study protocol. Protocol PDF